As a consequence of this delisting, trading in Cambium's ordinary shares will be suspended at the market open on March 27, 2026. The company is currently evaluating whether to appeal the delisting decision to the Nasdaq Listing and Hearing Review Council. However, it is important to note that such an appeal will not halt the suspension of trading.
Following the delisting, Cambium Networks expects its ordinary shares to be eligible for quotation on the OTCID market operated by OTC Markets under the trading symbol CMBM. This transition to the OTC market may have a significant adverse impact on the trading price and volume of the ordinary shares, as there is no guarantee that a market will develop or be maintained on the OTCID market. Shareholders may find it increasingly difficult to buy or sell their shares, which could lead to reduced liquidity and increased volatility.
The company issued a press release on March 26, 2026, announcing the receipt of the delisting notice, which is attached as Exhibit 99.1 to the Form 8-K filing. The press release outlines the implications of the delisting and the company's plans moving forward. Investors are cautioned to consider the risks associated with the potential delisting and the transition to the OTC market, as these factors could materially affect their investment in Cambium Networks Corporation.